WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--Saphena Medical, makers of Venapax, a unitary endoscopic vessel harvesting system, announced today that it has been awarded a contract with Premier’s highly committed SURPASS (Synergizing for Unparalleled Results in Procurement and Strategic Sourcing) program in the category of Endoscopic Vessel Harvesting. Premier Inc. is one of the largest performance improvement companies in the U.S.
The contract creates an endoscopic vessel harvesting category specifically for Premier‘s SURPASS membership. The sole-supplier agreement will further accelerate Venapax’s rapidly expanding share of the EVH market by providing members with the best pricing possible for Saphena’s cutting-edge system.
Premier Inc. (PINC) is a performance improvement healthcare company. Over the years, it has developed an alliance of more than 4,100 U.S. hospitals and health systems and over 200,000 other providers and organizations. SURPASS is a unique collaboration for Premier member health systems, designed to drive compliance and scale for the purchasing of clinically efficacious products across their systems in order to achieve best-in-market pricing.
“Saphena Medical is focused on simplifying the EVH procedure and drastically reducing its learning curve while providing Venapax at an optimized price point,” states Mike Glennon, Saphena’s CEO. “The SURPASS sole-source EVH agreement delivers real value for program participants while validating Venapax’s standing in the marketplace.”
About Venapax:
Venapax is Saphena Medical’s all-in-one comprehensive EVH system that provides dissection and simultaneous branch ligation in a simple, elegant device. It delivers a minimal-touch experience with a focus on specimen quality.
